P1.04-09 Immunomodulatory Effects of Afatinib and Pembrolizumab in EGFR-Mutant NSCLC with Progression on Prior EGFR-TKI

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2018-10, Vol.13 (10), p.S528-S528
Main Authors: Riess, J., Kelly, K., Schalper, K., Shimoda, M., Lim, S., Monjazeb, A., Danenberg, K., Moore, E., Beckett, L., Mack, P., Maverakis, E., Gandara, D.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2018.08.724